New Zealand markets closed

Kingchem (Liaoning) Life Science Co., Ltd. (301509.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
36.38-0.02 (-0.05%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 4.38B
Enterprise value 3.77B
Trailing P/E 25.72
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.84
Price/book (mrq)2.00
Enterprise value/revenue 5.57
Enterprise value/EBITDA 21.45

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-29.77%
S&P500 52-week change 322.55%
52-week high 379.29
52-week low 331.48
50-day moving average 337.05
200-day moving average 346.40

Share statistics

Avg vol (3-month) 32.65M
Avg vol (10-day) 35.57M
Shares outstanding 5120.45M
Implied shares outstanding 6120.45M
Float 844.89M
% held by insiders 169.50%
% held by institutions 17.65%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 42.20%
Trailing annual dividend rate 30.57
Trailing annual dividend yield 31.57%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 409 May 2024
Last split factor 21.4:1
Last split date 309 May 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 22.10%
Operating margin (ttm)11.70%

Management effectiveness

Return on assets (ttm)5.45%
Return on equity (ttm)9.76%

Income statement

Revenue (ttm)677.27M
Revenue per share (ttm)6.23
Quarterly revenue growth (yoy)-41.90%
Gross profit (ttm)N/A
EBITDA 220.87M
Net income avi to common (ttm)149.65M
Diluted EPS (ttm)1.42
Quarterly earnings growth (yoy)-58.80%

Balance sheet

Total cash (mrq)613.49M
Total cash per share (mrq)5.09
Total debt (mrq)6.09M
Total debt/equity (mrq)0.28%
Current ratio (mrq)21.36
Book value per share (mrq)18.18

Cash flow statement

Operating cash flow (ttm)254.16M
Levered free cash flow (ttm)-773.05M